Symbols / FHTX Stock $3.70 -6.92% Foghorn Therapeutics Inc.

Healthcare • Biotechnology • United States • NGM
FHTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Adrian H. B. Gottschalk
Exch · Country NGM · United States
Market Cap 217.24M
Enterprise Value 91.75M
Income -75.32M
Sales 28.22M
FCF (ttm) -36.93M
Book/sh -1.30
Cash/sh 3.13
Employees 106
Insider 10d —
IPO Oct 23, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -3.98
PEG —
P/S 7.70
P/B -2.84
P/C —
EV/EBITDA -1.18
EV/Sales 3.25
Quick Ratio 2.85
Current Ratio 2.92
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.17
EPS next Y -0.93
EPS Growth —
Revenue Growth -45.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-07
ROA -21.00%
ROE —
ROIC —
Gross Margin -190.88%
Oper. Margin -6.60%
Profit Margin -266.88%
Shs Outstand 58.71M
Shs Float 27.41M
Insider Own 17.94%
Instit Own 76.57%
Short Float 4.19%
Short Ratio 10.43
Short Interest 1.34M
52W High 6.95
vs 52W High -46.76%
52W Low 3.27
vs 52W Low 13.15%
Beta 2.97
Impl. Vol. 6.69%
Rel Volume 0.55
Avg Volume 159.49K
Volume 87.33K
Target (mean) $11.44
Tgt Median $12.00
Tgt Low $9.00
Tgt High $14.00
# Analysts 9
Recom Strong_buy
Prev Close $3.98
Price $3.70
Change -6.92%
About

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.44
Mean price target
2. Current target
$3.70
Latest analyst target
3. DCF / Fair value
$-11.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.70
Low
$9.00
High
$14.00
Mean
$11.44

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-12 reit Wedbush Outperform → Outperform $10
2026-03-10 reit HC Wainwright & Co. Buy → Buy $13
2026-02-17 main Jefferies Buy → Buy $12
2025-12-18 init BTIG — → Buy $11
2025-12-04 init Stifel — → Buy $12
2025-11-07 init Guggenheim — → Buy $12
2025-05-15 reit JMP Securities Market Outperform → Market Outperform $9
2025-04-30 reit JMP Securities Market Outperform → Market Outperform $9
2025-04-30 reit HC Wainwright & Co. Buy → Buy $13
2025-04-23 init JMP Securities — → Market Outperform $9
2025-03-07 reit HC Wainwright & Co. Buy → Buy $13
2025-01-30 init B. Riley Securities — → Buy $10
2024-12-17 reit HC Wainwright & Co. Buy → Buy $13
2024-12-16 main Jefferies Buy → Buy $14
2024-09-24 main Morgan Stanley Equal-Weight → Equal-Weight $9
2024-09-03 init Jefferies — → Buy $18
2024-08-19 init Evercore ISI Group — → Outperform $20
2024-08-12 reit HC Wainwright & Co. Buy → Buy $20
2024-08-09 reit Wedbush Outperform → Outperform $13
2024-05-07 reit HC Wainwright & Co. Buy → Buy $20
News
RSS: Latest FHTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-10 GOTTSCHALK ADRIAN Chief Executive Officer — 106,705 $0.00 $0
2025-04-25 GOTTSCHALK ADRIAN Chief Executive Officer — 300,000 $0.00 $0
2024-09-23 COSTA CARLOS FERNANDO Officer — 36,613 $3.72 $136,200
2024-09-23 COSTA CARLOS FERNANDO Officer — 36,613 $10.04 $367,706
2024-09-18 COSTA CARLOS FERNANDO Officer — 11,574 $3.72 $43,055
2024-09-18 COSTA CARLOS FERNANDO Officer — 11,574 $10.05 $116,319
2024-09-17 COSTA CARLOS FERNANDO Officer — 10,672 $3.72 $39,700
2024-09-17 COSTA CARLOS FERNANDO Officer — 10,672 $10.00 $107,131
2024-09-09 BELLON STEVEN F Officer — 20,000 $9.50 $190,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
30.91
+36.75%
22.60
-33.83%
34.16
+77.63%
19.23
Operating Revenue
30.91
+36.75%
22.60
-33.83%
34.16
+77.63%
19.23
Operating Expense
113.02
-8.03%
122.89
-13.50%
142.06
+4.18%
136.37
Research And Development
85.47
-9.59%
94.53
-13.82%
109.69
+3.85%
105.62
Selling General And Administration
27.55
-2.85%
28.36
-12.40%
32.37
+5.29%
30.75
General And Administrative Expense
27.55
-2.85%
28.36
-12.40%
32.37
+5.29%
30.75
Salaries And Wages
17.41
+1.69%
17.12
-16.73%
20.57
+12.73%
18.24
Other Gand A
10.13
-9.78%
11.23
-4.84%
11.81
-5.58%
12.50
Total Expenses
113.02
-8.03%
122.89
-13.50%
142.06
+4.18%
136.37
Operating Income
-82.11
+18.13%
-100.28
+7.06%
-107.91
+7.88%
-117.14
Total Operating Income As Reported
-86.39
+15.87%
-102.68
+4.84%
-107.91
+7.88%
-117.14
EBITDA
-78.78
+18.93%
-97.17
+6.98%
-104.45
+8.22%
-113.82
Normalized EBITDA
-74.49
+21.39%
-94.77
+9.27%
-104.45
+8.22%
-113.82
Reconciled Depreciation
3.33
+6.79%
3.12
-9.59%
3.45
+3.91%
3.32
EBIT
-82.11
+18.13%
-100.28
+7.06%
-107.91
+7.88%
-117.14
Total Unusual Items
-4.28
-78.57%
-2.40
0.00
0.00
Total Unusual Items Excluding Goodwill
-4.28
-78.57%
-2.40
0.00
0.00
Special Income Charges
-4.28
-78.57%
-2.40
0.00
0.00
Other Special Charges
-1.63
—
—
—
Impairment Of Capital Assets
—
2.40
0.00
—
Write Off
5.91
+146.62%
2.40
0.00
—
Net Income
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Pretax Income
-74.28
+14.24%
-86.62
+8.05%
-94.20
+13.48%
-108.88
Net Non Operating Interest Income Expense
8.74
-26.51%
11.90
+9.43%
10.88
+91.63%
5.67
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
8.74
-26.51%
11.90
+9.43%
10.88
+91.63%
5.67
Interest Expense
—
—
—
0.00
Interest Income Non Operating
8.74
-26.51%
11.90
+9.43%
10.88
+91.63%
5.67
Interest Income
8.74
-26.51%
11.90
+9.43%
10.88
+91.63%
5.67
Other Income Expense
-0.92
-152.18%
1.76
-37.65%
2.83
+9.73%
2.58
Other Non Operating Income Expenses
3.36
-19.26%
4.16
+47.05%
2.83
+9.73%
2.58
Tax Provision
—
0.00
-100.00%
4.23
0.00
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Net Income From Continuing Operation Net Minority Interest
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Net Income From Continuing And Discontinued Operation
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Net Income Continuous Operations
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Normalized Income
-70.00
+16.89%
-84.22
+14.43%
-98.43
+9.60%
-108.88
Net Income Common Stockholders
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Diluted EPS
—
-1.58
+32.48%
-2.34
+10.69%
-2.62
Basic EPS
—
-1.58
+32.48%
-2.34
+10.69%
-2.62
Basic Average Shares
—
54.90
+30.79%
41.97
+0.92%
41.59
Diluted Average Shares
—
54.90
+30.79%
41.97
+0.92%
41.59
Diluted NI Availto Com Stockholders
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
198.10
-30.24%
283.98
-0.68%
285.92
-29.38%
404.88
Current Assets
163.24
-34.60%
249.60
+3.92%
240.18
-31.65%
351.40
Cash Cash Equivalents And Short Term Investments
158.89
-34.81%
243.75
+4.14%
234.06
-32.31%
345.80
Cash And Cash Equivalents
80.88
+45.84%
55.45
-30.97%
80.34
+53.86%
52.21
Other Short Term Investments
78.02
-58.57%
188.29
+22.49%
153.72
-47.64%
293.58
Receivables
—
—
—
0.00
Accounts Receivable
—
—
—
0.00
Prepaid Assets
—
—
—
—
Restricted Cash
1.25
0.00
—
—
Other Current Assets
3.09
-47.20%
5.85
-4.41%
6.12
+9.34%
5.60
Total Non Current Assets
34.87
+1.42%
34.38
-24.83%
45.73
-14.49%
53.48
Net PPE
32.86
+0.79%
32.60
-24.02%
42.91
-13.13%
49.40
Gross PPE
39.87
-16.40%
47.69
-13.18%
54.93
-5.31%
58.01
Accumulated Depreciation
-7.00
+53.56%
-15.08
-25.52%
-12.02
-39.55%
-8.61
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
30.95
+36.69%
22.64
-24.42%
29.96
-12.12%
34.09
Machinery Furniture Equipment
0.89
-2.32%
0.91
-2.58%
0.93
+1.64%
0.92
Other Properties
38.98
+30.99%
29.76
-19.04%
36.76
-8.03%
39.97
Leases
0.00
-100.00%
17.02
-1.25%
17.24
+0.68%
17.12
Other Non Current Assets
2.00
+12.84%
1.78
-37.09%
2.82
-30.93%
4.09
Total Liabilities Net Minority Interest
306.60
-6.95%
329.51
-9.25%
363.11
-10.29%
404.77
Current Liabilities
59.74
-10.82%
66.99
+14.64%
58.44
+5.85%
55.20
Payables And Accrued Expenses
9.30
+22.83%
7.57
-31.06%
10.98
-3.25%
11.35
Payables
4.27
+12.71%
3.79
-45.41%
6.93
+28.08%
5.41
Accounts Payable
4.27
+12.71%
3.79
-39.54%
6.26
+15.63%
5.41
Current Accrued Expenses
5.04
+32.95%
3.79
-6.49%
4.05
-31.80%
5.94
Pensionand Other Post Retirement Benefit Plans Current
5.92
+24.86%
4.74
+9.09%
4.35
-8.35%
4.74
Total Tax Payable
—
0.00
-100.00%
0.67
0.00
Income Tax Payable
—
0.00
-100.00%
0.67
0.00
Current Debt And Capital Lease Obligation
0.92
-89.82%
9.07
+6.45%
8.52
+42.68%
5.97
Current Capital Lease Obligation
0.92
-89.82%
9.07
+6.45%
8.52
+42.68%
5.97
Current Deferred Liabilities
43.19
-5.29%
45.61
+32.00%
34.55
+5.27%
32.82
Current Deferred Revenue
43.19
-5.29%
45.61
+32.00%
34.55
+5.27%
32.82
Other Current Liabilities
0.40
+39900.00%
0.00
-97.22%
0.04
-88.68%
0.32
Total Non Current Liabilities Net Minority Interest
246.87
-5.96%
262.52
-13.83%
304.67
-12.84%
349.57
Long Term Debt And Capital Lease Obligation
40.35
+43.77%
28.06
-23.23%
36.55
-19.72%
45.54
Long Term Capital Lease Obligation
40.35
+43.77%
28.06
-23.23%
36.55
-19.72%
45.54
Non Current Deferred Liabilities
205.96
-12.15%
234.46
-12.55%
268.12
-11.80%
304.00
Non Current Deferred Revenue
205.96
-12.15%
234.46
-12.55%
268.12
-11.80%
304.00
Other Non Current Liabilities
0.56
—
—
0.03
Stockholders Equity
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Common Stock Equity
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Capital Stock
0.01
+0.00%
0.01
+50.00%
0.00
+0.00%
0.00
Common Stock
0.01
+0.00%
0.01
+50.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
56.66
+1.91%
55.59
+31.48%
42.28
+1.14%
41.80
Ordinary Shares Number
56.66
+1.91%
55.59
+31.48%
42.28
+1.14%
41.80
Additional Paid In Capital
523.94
+2.23%
512.51
+29.69%
395.20
+4.76%
377.23
Retained Earnings
-632.47
-13.31%
-558.18
-18.37%
-471.56
-26.38%
-373.14
Gains Losses Not Affecting Retained Earnings
0.02
-82.22%
0.14
+116.34%
-0.83
+79.28%
-3.99
Other Equity Adjustments
0.02
-82.22%
0.14
+116.34%
-0.83
+79.28%
-3.99
Total Equity Gross Minority Interest
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Total Capitalization
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Working Capital
103.50
-43.32%
182.61
+0.48%
181.75
-38.64%
296.19
Invested Capital
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Total Debt
41.27
+11.15%
37.13
-17.62%
45.07
-12.49%
51.51
Capital Lease Obligations
41.27
+11.15%
37.13
-17.62%
45.07
-12.49%
51.51
Net Tangible Assets
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Tangible Book Value
-108.50
-138.31%
-45.53
+41.02%
-77.19
-69019.64%
0.11
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-86.10
+14.25%
-100.41
+14.99%
-118.11
-161.00%
193.61
Cash Flow From Continuing Operating Activities
-86.10
+14.25%
-100.41
+14.99%
-118.11
-161.00%
193.61
Net Income From Continuing Operations
-74.28
+14.24%
-86.62
+11.99%
-98.43
+9.60%
-108.88
Depreciation Amortization Depletion
3.33
+6.79%
3.12
-9.59%
3.45
+3.91%
3.32
Depreciation
—
—
—
3.32
Depreciation And Amortization
3.33
+6.79%
3.12
-9.59%
3.45
+3.91%
3.32
Other Non Cash Items
2.57
-54.70%
5.68
+9.06%
5.21
+13.76%
4.58
Stock Based Compensation
10.40
-12.56%
11.89
-26.52%
16.19
+12.90%
14.34
Asset Impairment Charge
5.91
+146.62%
2.40
0.00
—
Operating Gains Losses
0.03
—
0.00
-50.00%
0.01
Gain Loss On Sale Of PPE
0.03
0.00
-100.00%
0.00
-50.00%
0.01
Change In Working Capital
-32.14
+0.39%
-32.27
+22.95%
-41.88
-114.87%
281.55
Change In Receivables
—
—
0.00
-100.00%
300.00
Changes In Account Receivables
—
—
—
300.00
Change In Prepaid Assets
2.83
+114.65%
1.32
+77.73%
0.74
+341.37%
-0.31
Change In Payables And Accrued Expense
2.69
+188.35%
-3.04
-219.56%
-0.95
-131.13%
3.06
Change In Accrued Expense
2.20
+490.78%
-0.56
+68.61%
-1.80
-224.71%
1.44
Change In Payable
0.48
+119.43%
-2.48
-392.55%
0.85
-47.58%
1.61
Change In Account Payable
0.48
+119.43%
-2.48
-392.55%
0.85
-47.58%
1.61
Change In Other Working Capital
-30.91
-36.75%
-22.60
+33.83%
-34.16
-140.07%
-14.23
Change In Other Current Liabilities
-6.74
+15.10%
-7.94
-5.70%
-7.51
-7.73%
-6.97
Investing Cash Flow
112.04
+474.67%
-29.90
-120.70%
144.45
+159.12%
-244.32
Cash Flow From Continuing Investing Activities
112.04
+474.67%
-29.90
-120.70%
144.45
+159.12%
-244.32
Net PPE Purchase And Sale
-0.05
+94.48%
-0.91
+25.98%
-1.22
-1.16%
-1.21
Purchase Of PPE
-0.05
+94.48%
-0.91
+25.98%
-1.22
-1.16%
-1.21
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.05
+94.48%
-0.91
+25.98%
-1.22
-1.16%
-1.21
Net Investment Purchase And Sale
112.09
+486.54%
-29.00
-119.91%
145.67
+159.92%
-243.11
Purchase Of Investment
-131.25
+49.80%
-261.47
-253.81%
-73.90
+81.95%
-409.35
Sale Of Investment
243.34
+4.67%
232.47
+5.87%
219.57
+32.09%
166.23
Financing Cash Flow
1.02
-99.03%
105.43
+5829.58%
1.78
+0.85%
1.76
Cash Flow From Continuing Financing Activities
1.02
-99.03%
105.43
+5829.58%
1.78
+0.85%
1.76
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
0.54
-99.48%
103.40
0.00
0.00
Proceeds From Stock Option Exercised
0.48
-81.51%
2.61
+46.91%
1.78
+0.85%
1.76
Net Other Financing Charges
—
-0.58
—
—
Changes In Cash
26.96
+208.37%
-24.88
-188.48%
28.12
+157.45%
-48.95
Beginning Cash Position
57.16
-30.33%
82.04
+52.15%
53.92
-47.58%
102.87
End Cash Position
84.13
+47.17%
57.16
-30.33%
82.04
+52.15%
53.92
Free Cash Flow
-86.15
+14.97%
-101.31
+15.10%
-119.33
-162.02%
192.40
Interest Paid Supplemental Data
—
—
—
0.00
Income Tax Paid Supplemental Data
0.01
-98.95%
0.86
-75.78%
3.55
0.00
Amortization Of Securities
-1.93
+58.25%
-4.61
-74.01%
-2.65
-104.71%
-1.29
Common Stock Issuance
0.54
-99.48%
103.40
0.00
0.00
Issuance Of Capital Stock
0.54
-99.48%
103.40
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category